RT @NIHDirector: #NIH has today launched a Phase 1 #clinicaltrial evaluating a vaccine candidate for #coronavirus #COVID19. This trial is enrolling 45 healthy adult volunteers in Seattle & is the first of multiple steps for evaluating the potential benefit of the vaccine. https://t.co/pudR3sL1zB

#NIH has today launched a Phase 1 #clinicaltrial evaluating a vaccine candidate for #coronavirus #COVID19. This trial is enrolling 45 healthy adult volunteers in Seattle & is the first of multiple steps for evaluating the potential benefit of the vaccine. https://t.co/pudR3sL1zB

— Francis S. Collins (@NIHDirector) March 16, 2020

March 17, 2020 at 10:40PM